Laguna Thrombectomy System (TRUST Study)
Pulmonary Embolism
Pre-clinical TrialActive
Key Facts
About Innova Vascular
Innova Vascular is a clinical-stage medical device company focused on thrombectomy solutions for vascular disease. Founded in 2017, the company has achieved key regulatory milestones, including FDA clearance for its Laguna Thrombectomy System in 2023 and early commercial use in 2024. Led by an experienced founder with a strong track record in device development and commercialization, Innova is positioned to address the significant market for minimally invasive treatment of pulmonary embolism and peripheral vascular clots.
View full company profileTherapeutic Areas
Other Pulmonary Embolism Drugs
| Drug | Company | Phase |
|---|---|---|
| Technegas® for Pulmonary Embolism | Cyclomedica | commercial |
| CLEANER Thrombectomy System (PE Indication) | Argon Medical Devices | Clinical Study |
| Cardiac & Vascular AI Suite | RapidAI | Commercial |
| Viz Vascular Suite | Viz.ai | Commercial |